Publication Name	World Journal of Gastroenterology
Manuscript ID	25285
Country	South Korea

Received	2016-03-03 08:44
Peer-Review Started	2016-03-04 08:44
To Make the First Decision	2016-04-14 09:23
Return for Revision	2016-04-15 08:52
Revised	2016-04-26 20:50
Second Decision	2016-05-10 17:44
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-05-23 16:56
Articles in Press	2016-05-23 16:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-06-02 15:47
Publish the Manuscript Online	2016-07-04 14:42

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Retrospective Study
Article Title	Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation
Manuscript Source	Unsolicited Manuscript
All Author List	Gun Hyung Na, Tae Ho Hong, Young Kyoung You and Dong Goo Kim
Funding Agency and Grant Number
Corresponding Author	Dong Goo Kim, MD, PhD, Professor, Department of Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul 137-701, South Korea. kimdg@catholic.ac.kr
Key Words	Hepatocellular carcinoma; Living donor liver transplantation; mTOR inhibitor; Recurrence; Selection criteria
Core Tip	Although survival rates after liver transplan-tation (LT) have improved dramatically, hepatocellular carcinoma (HCC) recurrence remains a significant problem and studies regarding the clinical outcomes and treatments of patients with HCC recurrence after LT are rare. In this study, satisfying the Milan criteria at living donor liver transplantation (LDLT) was important for recurrence rates after LDLT, but was not important for survival rates after HCC recurrence. Curative treatment for recurrent HCC after LDLT is the most important factor in survival rates after HCC recurrence. Combination treatments of sorafenib and an mTOR inhibitor could have survival benefits in patients with HCC recurrence after LT in the palliative treatment group.
Publish Date	2016-07-04 14:42
Citation	Na GH, Hong TH, You YK, Kim DG. Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation. World J Gastroenterol 2016; 22(25): 5790-5799
URL	http://www.wjgnet.com/1007-9327/full/v22/i25/5790.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i25.5790

Full Article (PDF)	WJG-22-5790.pdf
Full Article (Word)	WJG-22-5790.doc
Manuscript File	25285-Review.docx
Answering Reviewers	25285-Answering reviewers.pdf
Audio Core Tip	25285-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	25285-Conflict-of-interest statement.pdf
Copyright License Agreement	25285-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	25285-Instituitional review board statement.pdf
Non-Native Speakers of English Editing Certificate	25285-Language cerificate.pdf
Peer-review Report	25285-Peer-review(s).pdf
Scientific Misconduct Check	25285-Scientific misconduct check.pdf
Scientific Editor Work List	25285-Scientific editor work list.pdf